Trends in antimicrobial susceptibility of Streptococcus pneumoniae in the Tohoku district of Japan: A longitudinal analysis from 1998 to 2007

Tohoku Journal of Experimental Medicine

Volumn 220, Issue 1, 2010, Pages 47-57

  Suzuki, Kazumasa ^a   Nishimaki, Katsushi ^b   Okuyama, Kaori ^a   Katoh, Tadashi ^a   Yasujima, Minoru ^c   Chihara, Junichi ^d   Suwabe, Akira ^e   Shibata, Yoko ^f   Takahashi, Choichiro ^g   Takeda, Hiroaki ^h   Ida, Shiro ⁱ   Kaku, Mitsuo ^b   Watanabe, Akira ^j   Nukiwa, Toshihiro ^b   Niitsuma, Kazunao ^k   Kanemitsu, Keiji ^l   Takayanagi, Motoaki ^a   Ohno, Isao ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f YAMAGATA UNIVERSITY   (Japan)

^g YAMAGATA UNIVERSITY HOSPITAL   (Japan)

^h Yamagata Saisei Hospital   (Japan)

ⁱ Department of Internal Medicine   (Japan)

^j TOHOKU UNIVERSITY   (Japan)

^k Department of Internal Medicine   (Japan)

^l FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Multidrug resistance; Penicillin resistance; S. Pneumoniae; Serotype; Susceptibility

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFCAPENE; CEFDINIR; CEFDITOREN; ERYTHROMYCIN; LEVOFLOXACIN; MINOCYCLINE; PENICILLIN G; TOSUFLOXACIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INPATIENTS; JAPAN; LONGITUDINAL STUDIES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PENICILLIN G; RESPIRATORY SYSTEM; SEX CHARACTERISTICS; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 74949133177     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.220.47     Document Type: Article

References (48)

1. Anzueto, A., Bishai, W.R. & Pottumarthy, S. (2007) Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis. Diagn. Microbiol. Infect. Dis., 57, 31S-38S.
2. Bartlett, J.G., Dowell, S.F., Mandell, L.A., File, T.M. Jr., Musher, D.M. & Fine, M.J. (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis., 31, 347-382.
3. Biedenbach, D.J. & Jones, R.N. (2009) Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations. Diagn. Microbiol. Infect. Dis., 64, 202-212.
4. Bronzwaer, S., Cars, O., Buchholz, U., Mölstad, S., Goettsch, W., Veldhuijzen, I.K., Kool, J.L., Sprenger, M. & Degener, J.E. (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis., 8, 278-282.
5. Bruinsma, N., Kristinsson, K.G., Bronzwaer, S., Schrijnemakers, P., Degener, J., Tiemersma, E., Hryniewicz, W., Monen, J. & Grundmann, H. (2004) Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother., 54, 1045-1050.
6. Chiba, N., Kobayashi, R., Hasegawa, K., Morozumi, M., Nakayama, E., Tajima, T., Iwata, S. & Ubukata, K.; Acute Respiratory Diseases Study Group. (2005) Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. J. Antimicrob. Chemother., 56, 756-760.
7. Clinical and Laboratory Standards Institute (CLSI). (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard-seventh edition. CLSI document M7-A7. Wayne, PA.
8. Clinical and Laboratory Standards Institute (CLSI). (2007) Performance standards for antimicrobial susceptibility testing: 17th informational supplement M100-S17. Wayne, PA.
9. Clinical and Laboratory Standards Institute (CLSI). (2008) Performance standards for antimicrobial susceptibility testing: 18th informational supplement M100-S18. Wayne, PA.
10. Cohen, R. (2009) The need for prudent use of antibiotics and routine use of vaccines. Clin. Microbiol. Infect., 15, 21-23.
11. Doern, G.V., Heilmann, K.P., Huynh, H.K., Rhonberg, P.R., Coffman, S.L. & Brueggemann, A.B. (2001) Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother., 45, 1721-1729.
12. Doern, G.V., Richter, S.S., Miller, A., Miller, N., Rice, C., Heilmann, K. & Beekmann, S. (2005) Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin. Infect. Dis., 41, 139-148.
13. Felmingham, D., Cantón, R. & Jenkins, S.G. (2007) Regional trends in â-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J. Infect., 55, 111-118.
14. File, T.M. Jr. (2006) Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin. Microbiol. Infect., 12, S31-41.
15. Goossens, H., Ferech, M., Stichele, R.V. & Elseviers, M. (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 365, 579-587.
16. Harimaya, A., Yokota, S., Sato, K., Koizumi, J., Yamazaki, N., Himi, T. & Fujii, N. (2006) Alterations of pbp1a, pbp2b, and pbp2x in Streptococcus pneumoniae isolates from children with otolaryngological infectious disease in the Sapporo district of Japan. J. Infect. Chemother., 12, 366-371.
17. Hirakata, Y., Yanagihara, K., Miyazaki, Y., Tomono, K., Kobayashi, I. & Kohno, S. (2005) Antimicrobial susceptibilities of potential bacterial pathogens in adults with acute respiratory tract infections Prospective Epidemiological Network Investigating Community-acquired Infection SurveiLLance In Nagasaki (PENICILLIN) Study. Diagn. Microbiol. Infect. Dis., 51, 271-280.
18. Hoban, D.J., Doern, G.V., Fluit, A.C., Roussel-Delvallez, M. & Jones, R.N. (2001) Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis., 32, S81-93.
19. Hotomi, M., Billal, D.S., Kamide, Y., Kanesada, K., Uno, Y., Kubo F., Ito, M., Kakehata, S., Sugita, R., Ogami, M. & Yamanaka, M. (2008) Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. J. Clin. Microbiol., 46, 3808-3810.
20. Inoue, M., Farrell, D.J., Kaneko, K., Akizawa, K., Fujita, S, Kaku, M., Igari, J., Yamaguchi, K., Yamanaka, K., Murase, M., Asari, S., Hirakata, Y., Baba, H. & Itaha, H. (2008) Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). Microb. Drug Resist., 14, 109-117.
21. Jenkins, S.G., Brown, S.D. & Farrell, D.J. (2008) http://www.ann-clinmicrob.com/content/7/1/1 BioMed Central Ltd.
22. Karchmer, A.W. (2004) Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - an update. Clin. Infect. Dis., 39, S142-150.
23. Karlowsky, J.A., Thornsberry, C., Critchley, I.A., Jones, M.E., Evangelista, A.T., Noel, G.J. & Sahm, D.F. (2003) Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrob. Agents Chemother., 47, 1790-1797.
24. Kyaw, M.H., Lynfield, R., Schaffner, W., Craig, A.S., Hadler, J., Reingold, A., Thomas, A.R., Harrison, L.H., Bennett, N.M., Farley, M.M., Facklam, R.R., Jorgensen, J.H., Besser, J., Zell, E.R., Schuchat, A. & Whitney, C.G. (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med., 354, 1455-1463.
25. Nakamura, T. & Takahashi, H. (2004) Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmaco-dynamics theory. Jpn. J. Antibiot., 57, 465-474.
26. Niederman, M.S. (2005) Principles of appropriate antibiotic use. Int. J. Antimicrob. Agents, 26, S170-175.
27. Niederman, M.S., Mandell, L.A., Anzueto, A., Bass, J.B., Broughton, W.A., Campbell, G.D., Dean, N., File, T., Fine, M.J., Gross, P.A., Martinez, F., Marrie, T.J., Plouffe, J.F., Ramirez, J., Sarosi, G.A., Torres, A., Wilson, R. & Yu, V.L. (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med., 163, 1730-1754.
28. Niki, Y., Hanaki, H., Matsumoto, T., Yagisawa, M., Kohno, S., Aoki, N., Watanabe, A., Sato, J., Hattori, R., Terada, M., Koashi, N., Kozuki, T., Maruo, A., Morita, K., Ogasawara, K., Takahashi, Y., Watanabe, J., Takeuchi, K., Fujimura, S., Takeda, H., Ikeda, H., Sato, N., Niitsuma, K., Saito, M., Koshiba, S., Kaneko, M., Miki, M., Nakanowatari, S., Honda, Y., Chiba, J., Takahashi, H., Utagawa, M., Kondo, T., Kawana, A., Konosaki, H., Aoki, Y., Ueda, H., Sugiura, H., Ichioka, M., Goto, H., Kurai, D., Okazaki, M., Yoshida, K., Yoshida, T., Tanabe, Y., Kobayashi, S., Okada, M., Tsukada, H., Imai, Y., Honma, Y., Nishikawa, K., Yamamoto, T., Kawai, A., Kashiwabara, T., Takesue, Y., Wada, Y., Nakajima, K., Miyara, T., Toda, H., Mitsuno, N., Sugimura, H., Yoshioka, S., Kurokawa, M., Munekawa, Y., Nakajima, H., Kubo, S., Ohta, Y., Mikasa, K., Maeda, K., Kasahara, K., Koizumi, A., Sano, R., Yagi, S., Takaya, M., Kurokawa, Y., Kusano, N., Mihara, E., Kuwabara, M., Fujiue, Y., Ishimaru, T., Matsubara, N., Kawasaki, Y., Tokuyasu, H., Masui, K., Negayama, K., Ueda, N., Ishimaru, M., Nakanishi, Y., Fujita, M., Honda, J., Kadota, J., Hiramatsu, K., Aoki, Y., Nagasawa, Z., Suga, M., Muranaka, H., Yanagihara, K., Fujita, J., Tateyama, M., Sunakawa, K. & Totsuka, K. (2009) Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility. J. Infect. Chemother., 15, 156-167.
29. Niki, Y., Hanaki, H., Yagisawa, M., Kohno, S., Aoki, N., Watanabe, A., Sato, J., Hattori, R., Koashi, N., Kozuki, T., Maruo, A., Morita, K., Ogasawara, K., Takahashi, Y., Watanabe, J., Takeuchi, K., Takahashi, M., Takeda, H., Ikeda, H., Kaneda, H., Niitsuma, K., Saito, M., Koshiba, S., Kaneko, M., Itabashi, S., Miki, M., Nakanowatari, S., Honda, Y., Chiba, J., Takahashi, H., Utagawa, M., Kondo, T., Kawana, A., Konosaki, H., Aoki, Y., Chonabayashi, N., Ueda, H., Sugiura, H., Ichioka, M., Goto, H., Aoshima, M., Okazaki, M., Ozawa, T., Horiuchi, F., Yoshida, T., Tsukada, H., Kobayashi, S., Yoshikawa, H., Imai, Y., Aoki, N., Honma, Y., Yoshida, K., Takaya, M., Kurokawa, Y., Kuwabara, M., Fujiue, Y., Ishimaru, T., Matsubara, N., Kawasaki, Y., Tokuyasu, H., Masui, K., Shimizu, E., Yoneda, K., Negayama, K., Ueda, N., Ishimaru, M., Nakanishi, Y., Fujita, M., Honda, J., Kadota, J., Hiramatsu, K., Aoki, Y., Nagasawa, Z., Suga, M., Muranaka, H., Kohno, S., Yanagihara, K., Fujita, J., Tateyama, M. & Totsuka, K. (2008) The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. J. Infect. Chemother., 14, 279-290.
30. Noguchi, N., Tano, J., Nasu, Y., Koyama, M., Narui, K., Kamishima, H., Saito, T., Tsuyuki, K. & Sasatsu, M. (2007) Antimicrobial susceptibilities and distribution of resistance genes for â-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo. Int. J. Antimicrob. Agents, 29, 26-33.
31. Oishi, K.,Yoshimine, H., Watanabe, H., Watanabe, K., Tanimura, S., Kawakami, K., Iwagaki, A., Nagai, H., Goto, H., Kudoh, S., Kuriyama, T., Fukuchi, Y., Matsushima, T., Shimada, K., Matsumoto, K. & Nagatake, T. (2006) Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan. Respirology., 11, 429-436.
32. Örtqvist, Å., Hedlund, J. & Kalin, M. (2005) Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin. Respir. Crit. Care Med., 26, 563-574.
33. Peric, M., Browne, FA., Jacobs, M.R. & Appelbaum, P.C. (2003) Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/ pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. Clin. Ther., 25, 169-177.
34. Richter, S.S., Heilmann, K.P., Dohrn, C.L., Raihi, F., Beekmann, S.E. & Doern, G.V. (2009) Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin. Infect. Dis., 48, e23-33.
35. Rikitomi, N., Sow, P.S., Watanabe, K., Nunez, D.S., Martinez, G. & Nagatake, T. (1996) Rapid increase of pneumococcal resistance to â-lactam and other antibiotics in isolates from the respiratory tract (Nagasaki, Japan: 1975-1994). Microbiol. Immunol., 40, 899-905.
36. Saito, A. (1995) Clinical Breakpoint for Antimicrobial Agents in Pulmonary Infections and Sepsis: Report of the Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria. J. Infect. Chemother., 1, 83-88.
37. Saito, A., Inamatsu, T., Okada, J., Oguri, T., Kanno, H., Kusano, N., Kumon, H., Yamaguchi, K., Watanabe, A. & Watanabe, K. (1999) Clinical breakpoints in pulmonary infections and sepsis: new antimicrobial agents and supplemental information for some agents already released. J. Infect. Chemother., 5, 223-226.
38. Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E., Mone, J., Goossens, H. & Ferech, M. (2008) Antimicrobial drug use and resistance in Europe. Emerg. Infect. Dis., 14, 1722-1730.
39. Song, J.H., Lee, N.Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C.H., Lalitha, M.K., Thomas, K., Perera, J., Yee, T.T., Jamal, F., Warsa, U.C., Vinh, B.X., Jacobs, M.R., Appelbaum, P.C. & Pai, C.H. (1999) Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin. Infect. Dis., 28, 1206-1211.
40. The Japanese Respiratory Society. (2000) The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults, 1st ed., Tokyo.
41. The Japanese Respiratory Society. (2003) The Japanese Respiratory Society guidelines for the management of respiratory tract infection, 1st ed., Tokyo.
42. Ubukata, K. (2003) Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. J. Infect. Chemother., 9, 285-291.
43. Ubukata, K., Iwata, S. & Sunakawa, K. (2003) In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J. Infect. Chemother., 9, 221-226.
44. Vallès, X., Marcos, A., Pinart, M., Piñer, R., Marco, F., Mensa, J.M. & Torres, A. (2006) Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae : Has resistance to antibiotics decreased? Chest, 130, 800-806.
45. Watanabe, H., Sato, S., Kawakami, K., Watanabe, K., Oishi, K., Rikitomi, N., Ii, T., Ikeda, H., Sato, A. & Nagatake, T. (2000) A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital. Respirology, 5, 59-64.
46. Yamada, M., Watanabe, T., Miyara, T., Baba, N., Saito, J., Takeuchi, Y. & Ohsawa, F. (2007) Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin- binding protein 2X: structural basis for its high antimicrobial activity. Antimicrob. Agents Chemother., 51, 3902-3907.
47. Yamaguchi, K. & Ohno, A. (2005) Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002. Diagn. Microbiol. Infect. Dis., 52, 135-143.
48. Zapun, A., Contreras-Martel, C. & Vernet, T. (2008) Penicillin-binding proteins and beta- lactam resistance. FEMS Microbiol. Rev., 32, 361-385.